Risk and protection factors of mental stress among medical staff in the third year of the COVID-19 pandemic by Christiane Eichenberg, Raphaela Schneider, Phillip Auvera, Gabor Aranyi, Gabor Aranyi, Kurt Huber, Kurt Huber

Get full text

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how by Marie Muthspiel, Christoph C. Kaufmann, Achim Leo Burger, Benjamin Panzer, Freek W. A. Verheugt, Kurt Huber, Kurt Huber

Get full text

The Paradigm Change of IL-33 in Vascular Biology by Svitlana Demyanets, Stefan Stojkovic, Kurt Huber, Johann Wojta

Get full text

Red Cell Distribution Width Upon Hospital Admission Predicts Short-Term Mortality in Hospitalized Patients With COVID-19: A Single-Center Experience by Christoph C. Kaufmann, Amro Ahmed, Ulrich Brunner, Bernhard Jäger, Gabriele Aicher, Susanne Equiluz-Bruck, Alexander O. Spiel, Georg-Christian Funk, Michael Gschwantler, Peter Fasching, Kurt Huber, Kurt Huber

Get full text

New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease by Achim Leo Burger, Edita Pogran, Marie Muthspiel, Christoph Clemens Kaufmann, Bernhard Jäger, Kurt Huber

Get full text

Association of Plasma Methylglyoxal Increase after Myocardial Infarction and the Left Ventricular Ejection Fraction by Stefan Heber, Paul M. Haller, Attila Kiss, Bernhard Jäger, Kurt Huber, Michael J. M. Fischer

Get full text

Biomarkers Associated with Cardiovascular Disease in COVID-19 by Christoph C. Kaufmann, Amro Ahmed, Achim Leo Burger, Marie Muthspiel, Bernhard Jäger, Johann Wojta, Kurt Huber

Get full text

Twenty-four-hour time dependency of clopidogrel effects in patients with acute coronary syndromes: The CiCAD-Study by Susanne Claudia Gruber, Matthias Karl Freynhofer, Martin Willheim, Thomas Werner Weiss, Florian Egger, Wolfgang Hübl, Kurt Huber

Get full text

Copeptin Predicts Mortality in Critically Ill Patients. by Konstantin A Krychtiuk, Maria C Honeder, Max Lenz, Gerald Maurer, Johann Wojta, Gottfried Heinz, Kurt Huber, Walter S Speidl

Get full text

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention by Maximilian Tscharre, Maximilian Tscharre, Serdar Farhan, Matthias K. Freynhofer, Michael Leutner, Sabina Baumgartner-Parzer, Ioannis Tentzeris, Birgit Vogel, Florian Tinhofer, Miklos Rohla, Miklos Rohla, Thomas W. Weiss, Thomas W. Weiss, Kurt Huber, Kurt Huber, Alexandra Kautzky-Willer, Alexandra Kautzky-Willer

Get full text

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro. by Stefan P Kastl, Katharina M Katsaros, Konstantin A Krychtiuk, Gerlinde Jägersberger, Christoph Kaun, Kurt Huber, Johann Wojta, Walter S Speidl

Get full text

The association of P2Y12 inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery disease by Paul M Haller, Stefan Stojkovic, Edita Piackova, Tijana Andric, Lukas Wisgrill, Andreas Spittler, Johann Wojta, Kurt Huber, Bernhard Jäger

Get full text

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome by Stefan Stojkovic, Stephanie Kampf, Olesya Harkot, Maja Nackenhorst, Mira Brekalo, Kurt Huber, Christian Hengstenberg, Christoph Neumayer, Johann Wojta, Svitlana Demyanets

Get full text

The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome by Edita Pogran, Paul M. Haller, Claudia Wegberger, Maximilian Tscharre, Irena Vujasin, Christoph C. Kaufmann, Petra Dick, Bernhard Jäger, Johann Wojta, Kurt Huber

Get full text

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors by Patricia P. Wadowski, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Benjamin Panzer, Kurt Huber, Irene M. Lang, Renate Koppensteiner, Simon Panzer, Thomas Gremmel

Get full text

Relationship Between Arterial Access and Outcomes in ST‐Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights... by Jay Shavadia, Robert Welsh, Anthony Gershlick, Yinggan Zheng, Kurt Huber, Sigrun Halvorsen, Phillipe G. Steg, Frans Van de Werf, Paul W. Armstrong

Get full text

Immature cell fractions after cessation of chronic P2Y12-inhibition in patients with coronary artery diseases by Bernhard Jäger, Kris G. Vargas, Paul M. Haller, Stefan Stojkovic, Christoph C. Kaufmann, Matthias Freynhofer, Peter Quehenberger, Oswald Wagner, Johann Wojta, Kurt Huber

Get full text

Soluble neprilysin and survival in critically ill patients by Max Lenz, Konstantin A. Krychtiuk, Mira Brekalo, Dominik F. Draxler, Noemi Pavo, Christian Hengstenberg, Kurt Huber, Martin Hülsmann, Gottfried Heinz, Johann Wojta, Walter S. Speidl

Get full text

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Tria... by Paul M. Haller, Bernhard Jäger, Edita Piackova, Larissa Sztulman, Claudia Wegberger, Johann Wojta, Mariann Gyöngyösi, Attila Kiss, Bruno K. Podesser, Andreas Spittler, Kurt Huber

Get full text

Lipid-Lowering Therapy after Acute Coronary Syndrome by Edita Pogran, Achim Leo Burger, David Zweiker, Christoph Clemens Kaufmann, Marie Muthspiel, Gersina Rega-Kaun, Alfa Wenkstetten-Holub, Johann Wojta, Heinz Drexel, Kurt Huber

Get full text